title: Surgical management of oligometastatic non-small cell lung cancer.
abstract: The oligometastatic stage IV non-small cell lung cancer (NSCLC) offers a new surgical opportunity. New reported data is showing that surgery can offer a reasonable benefit, in terms of long-term survival, to some patients. The advantages of surgical treatment rely on a more adequate patient selection and a better understanding of the biology of these tumors. Currently, mediastinal involvement of the primary tumor can be identified as the most important prognostic variable after curative-intent of synchronous or metachronous metastasis. It seems clear that the routine use of combined FDG-PET and CT will help to detect the more favorable cohort of oligometastatic patients. As expected, pathological T staging of the primary tumor and the completeness of its resection are also crucial factors influencing final results. The real benefit of the local treatment over synchronous or metachronous metastasis is controversial with series showing better outcomes for metachronous lesions than for synchronous and others offering equal results. Also non conclusive results appear when analyzing different sites of metastasis. Retrospective series tend to show different outcomes depending on the affected organ while usually no differences are found in prospective ones. Most of the current evidence is based on retrospective studies on patients collected along extended periods of time. That represents a great limitation to the knowledge on this topic. Some prospective analyses have added some insight, but still the quality of the evidence is too low to allow drawing robust conclusions. As frequently concluded, prospective well designed investigation is requested to ascertain the value of surgery in this specific population of patients with extended NSCLC.
authors.affiliation: General Thoracic Service, University Hospital of Salamanca, Salamanca, Spain.
authors.forename: Nuria M
authors.initials: NM
authors.lastname: Novoa
authors.affiliation: General Thoracic Service, University Hospital of Salamanca, Salamanca, Spain.
authors.forename: Gonzalo
authors.initials: G
authors.lastname: Varela
authors.affiliation: General Thoracic Service, University Hospital of Salamanca, Salamanca, Spain.
authors.forename: Marcelo F
authors.initials: MF
authors.lastname: Jiménez
keywords: Non-small cell lung cancer (NSCLC); oligometastasis; oligometastatic stage; stage IV; surgical treatment